Quantcast

Latest Aastrom Biosciences Inc. Stories

2012-07-31 11:45:52

In the first human study of its kind, researchers found that using stem cells to re-grow craniofacial tissues–mainly bone–proved quicker, more effective and less invasive than traditional bone regeneration treatments. Researchers from the University of Michigan School of Dentistry and the Michigan Center for Oral Health Research partnered with Ann Arbor-based Aastrom Biosciences Inc. in the clinical trial, which involved 24 patients who required jawbone reconstruction after...

2010-05-03 14:20:00

ANN ARBOR, Mich., May 3 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announces the following webcast: What: Investor conference call to present an update on clinical development efforts related to critical limb ischemia (CLI). The event will also feature a Q&A session with Anthony J. Comerota, MD, FACS, FACC, director of the Jobst Vascular Center in Toledo, Ohio. When: Monday, May 10, 2010 @ 1:00 pm (ET) Where:...

2009-12-09 10:51:00

ANN ARBOR, Mich., Dec. 9 /PRNewswire-FirstCall/ -- Aastrom Biosciences (Nasdaq: ASTM) announces the following Webcast: What: Aastrom Biosciences Fiscal Year 2009 Annual Meeting of Shareholders When: Monday, December 14, 2009 @ 4:00 pm (Eastern) Where: http://www.investorcalendar.com/IC/CEPage.asp?ID=151462 How: For live Internet access, simply log on to the web at the link above. Shareholders and other interested parties will be able to...

2008-11-07 15:00:00

ANN ARBOR, Mich., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today reported financial results for the first fiscal quarter ended September 30, 2008. The Company also reported several recent clinical and operational achievements, including: * U.S. Phase II cardiac regeneration clinical trial opens first two clinical sites The Methodist Hospital in Houston, TX and Baylor University Medical Center in Dallas,...

2008-11-07 12:00:23

ANN ARBOR, Mich., Nov. 7, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that Martin C. Peters, PhD, Senior Director, Business Strategy & Market Development, will present at the Rodman & Renshaw 10th Annual Healthcare Conference. The conference will be held November 10-12th at The New York Palace Hotel in New York City, NY. Dr. Peters will present at 5:20 p.m. (Eastern Time), on Tuesday, November 11, 2008. A...

2008-10-30 12:01:03

ANN ARBOR, Mich., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that the 30th patient has been treated in the Company's U.S. Phase IIb RESTORE-CLI clinical trial. This milestone marks the first step toward interim data retrieval from this clinical trial evaluating Aastrom's Vascular Repair Cells (VRCs) in the treatment of patients suffering from the most severe form of peripheral arterial disease (PAD),...

2008-08-29 09:01:03

ANN ARBOR, Mich., Aug. 29, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today reported financial results for the fourth quarter and fiscal year ended June 30, 2008. The Company also reported clinical and operational achievements during the quarter, including: * Encouraging clinical data from the first two patients treated with Aastrom's autologous stem cell therapy for dilated cardiomyopathy (DCM), a type of...

2008-07-31 12:01:05

ANN ARBOR, Mich., July 31, 2008 (PRIME NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) ), a leading regenerative medicine company, today announced that George Dunbar, President and Chief Executive Officer, will present at the 2008 BMO Capital Markets Focus on Healthcare Conference. The conference will be held August 5-6th at the Millennium Broadway Hotel in New York City. Aastrom will present on Tuesday, August 5, 2008 at 3:00 p.m. (Eastern Time). A live audio webcast of Aastrom's...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related